Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McCune

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Therapeutic Drug Monitoring|March 6, 2021
Quality Control of Busulfan Plasma Quantitation, Modeling, and Dosing: An Interlaboratory Proficiency Testing ProgramJeannine S McCune, Arjen M Punt, Rosa F Yeh, et al.
Journal of Clinical Pharmacology|December 8, 2010
Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipientsNissa Abbasi, Barbara Vadnais, Jennifer A Knutson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host diseasePaul A Carpenter, James Lowder, Laura Johnston, et al.
Cancer Research|July 29, 2015
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic CancerTong Li, Yak-Nam Wang, Tatiana D Khokhlova, et al.
American Journal of Hematology|October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemiaElizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Clinical and Translational Science|August 20, 2024
Challenges with sirolimus experimental data to inform QSP model of post-transplantation cyclophosphamide regimensEzhilpavai Mohanan, Guofang Shen, Suping Ren, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2017
Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancerNavid Farr, Yak-Nam Wang, Samantha D'Andrea, et al.
Nature Materials|February 3, 2025
Printable molecule-selective core-shell nanoparticles for wearable and implantable sensingMinqiang Wang, Cui Ye, Yiran Yang, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Therapeutic Drug Monitoring|March 6, 2021
Quality Control of Busulfan Plasma Quantitation, Modeling, and Dosing: An Interlaboratory Proficiency Testing ProgramJeannine S McCune, Arjen M Punt, Rosa F Yeh, et al.
Journal of Clinical Pharmacology|December 8, 2010
Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipientsNissa Abbasi, Barbara Vadnais, Jennifer A Knutson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host diseasePaul A Carpenter, James Lowder, Laura Johnston, et al.
Cancer Research|July 29, 2015
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic CancerTong Li, Yak-Nam Wang, Tatiana D Khokhlova, et al.
American Journal of Hematology|October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemiaElizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Clinical and Translational Science|August 20, 2024
Challenges with sirolimus experimental data to inform QSP model of post-transplantation cyclophosphamide regimensEzhilpavai Mohanan, Guofang Shen, Suping Ren, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2017
Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancerNavid Farr, Yak-Nam Wang, Samantha D'Andrea, et al.
Nature Materials|February 3, 2025
Printable molecule-selective core-shell nanoparticles for wearable and implantable sensingMinqiang Wang, Cui Ye, Yiran Yang, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Pageof 18